Madden Securities’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.4M Hold
23,005
0.42% 58
2025
Q4
$1.24M Sell
23,005
-1,719
-7% -$82.7K 0.38% 59
2025
Q3
$1.12M Sell
24,724
-23,426
-49% -$1.09M 0.34% 60
2025
Q2
$2.23M Buy
48,150
+38,470
+397% +$1.89M 0.75% 35
2025
Q1
$590K Buy
9,680
+105
+1% +$6.12K 0.23% 77
2024
Q4
$542K Hold
9,575
0.22% 79
2024
Q3
$495K Buy
9,575
+1,000
+12% +$46.9K 0.21% 77
2024
Q2
$356K Buy
+8,575
New +$384K 0.16% 82
2023
Q3
Sell
-3,250
Closed -$208K 86
2023
Q2
$208K Sell
3,250
-8,095
-71% -$543K 0.11% 85
2023
Q1
$786K Hold
11,345
0.42% 51
2022
Q4
$816K Sell
11,345
-110
-1% -$8.29K 0.43% 50
2022
Q3
$814K Hold
11,455
0.49% 46
2022
Q2
$882K Hold
11,455
0.48% 50
2022
Q1
$837K Hold
11,455
0.38% 57
2021
Q4
$714K Hold
11,455
0.33% 64
2021
Q3
$678K Hold
11,455
0.37% 63
2021
Q2
$765K Buy
11,455
+100
+0.9% +$6.52K 0.4% 65
2021
Q1
$717K Sell
11,355
-125
-1% -$7.78K 0.42% 68
2020
Q4
$712K Sell
11,480
-1,010
-8% -$62.1K 0.46% 65
2020
Q3
$753K Sell
12,490
-200
-2% -$12K 0.56% 54
2020
Q2
$746K Buy
+12,690
New +$759K 0.66% 48
2019
Q4
$1.64M Buy
+25,524
New +$1.46M 1.64% 12

Other funds holding BMY

Madden Securities's BMY Position: Q1 2026 in Review

Madden Securities held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 23,005 shares worth $1.4M. The position accounts for 0.42% of the portfolio, ranked #58.

Madden Securities first reported a position in BMY in Q4 2019 and has held it in 22 quarters since. The position peaked at $2.23M in Q2 2025. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Madden Securities held 23,005 shares of Bristol-Myers Squibb worth $1.4M as of Q1 2026.
  • Madden Securities left its Bristol-Myers Squibb share count unchanged in Q1 2026.
  • Bristol-Myers Squibb made up 0.42% of Madden Securities's portfolio in Q1 2026, its #58 holding.
  • Madden Securities first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 22 quarters since.
  • Madden Securities's Bristol-Myers Squibb position peaked at $2.23M in Q2 2025.
  • 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Madden Securities's 13F filing for Q1 2026, filed 5 May 2026.